Palantir's Hospital Win Lands as NHS Quietly Deletes Its Own Case Study

Tampa General Hospital disclosed yesterday that it is teaming up with Palantir to build out analytical capabilities for its Reliability Management System — a tie-up trained on one specific piece of hospital infrastructure rather than the sprawling, organization-wide deployments the data group usually touts.

The announcement lands during a quarter in which Palantir's American commercial book has become its single biggest revenue engine. On November 2 the company reported third-quarter 2026 revenue of $2.31 billion, up 96% year over year. Sales to US commercial customers climbed 148% to $984 million, overtaking revenue from US government clients for the first time.

Guidance Raised, Order Book Flat

Management lifted its full-year revenue outlook to a range of $8.530 billion to $8.534 billion, and guided fourth-quarter sales to between $2.649 billion and $2.65 billion. Alongside the quarterly release, Palantir raised its 2026 revenue growth forecast to 91% and projected 143% growth in its US commercial business.

The numbers beat expectations on both the top and bottom lines, yet the stock came under pressure. Axios, writing on November 4, pointed to a backlog that was largely flat versus the prior quarter, combined with investor unease about how durable the AI-driven expansion really is and about the company's rich valuation. Shares were up 0.8% in the session tied to the Tampa General news.

A Commercial Pipeline That Keeps Widening

The hospital deal is the latest in a string of commercial partnerships. On November 5, Palantir and AmeriLife announced a company-wide collaboration aimed at accelerating AI-driven change across the distribution of insurance and retirement products. A day earlier, Changshin and Palantir said they would link shoe development and factory operations through data and AI. Each agreement targets a different corner of the economy — hospital operations, insurance distribution, footwear manufacturing — but all follow the same playbook of embedding Palantir's software into day-to-day workflows.

The Other Side of the Public-Sector Coin

Not every headline has been friendly. NHS England yesterday removed an online claim that 137 hospital trusts were benefiting from Palantir's Federated Data Platform, according to the Guardian. A investigation by the newspaper had found that 29 trusts were not using the technology at all, or were largely not using it.

The Guardian reported on Monday on published WhatsApp messages showing Palantir lobbying health minister Zubir Ahmed to extend its Foundry platform to GP records — a category explicitly excluded from the scope of the existing NHS contract. The disclosure puts a spotlight on how aggressively the company is pushing to widen its footprint inside Britain's health service, even as the official account of current usage was being scaled back.

For investors, the two threads — a commercial business expanding at triple-digit rates and a public-sector story that keeps generating friction — sit awkwardly side by side. The Tampa General win adds another logo to the commercial column. Whether it, and the deals with AmeriLife and Changshin, can keep the growth rate aloft is the question the market has been asking since the order book stalled.